Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 40 announcements

Share price
₹1,391.10
Market cap
₹6,407 Cr
Revenue (annual)
₹632.6 Cr
Net profit (annual)
₹115.4 Cr
P/E (TTM)
50.7×Sector 47.4×
Promoter holding
45.82%+0.00% QoQ
FII holding
6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:50 IST NSE
Management Change

Senores Pharmaceuticals Management Change

Senores Pharmaceuticals appointed Shilpa Sharma as Company Secretary and Viranchi Arvindbhai Shah as Independent Director. The board also approved a new ESOP scheme.

16:08 IST NSE
Management Change

Senores Pharmaceuticals Management Change

Senores Pharmaceuticals Limited has appointed Ms. Anjali Shah as Assistant Vice President - Finance, effective July 27, 2026. She brings over 10 years of experience in finance.

19:09 IST BSE
Management Change

Senores Pharmaceuticals Management Change

Senores Pharmaceuticals announced the cessation of its Company Secretary and Compliance Officer effective June 10, 2026. The company has designated other KMPs for disclosure responsibilities.